Results 191 to 200 of about 26,959 (237)
Transcatheter aortic valve implantation: the procedure
Heart, 2012 Transcatheter aortic valve implantation (TAVI) for the treatment of symptomatic severe aortic stenosis has emerged as an effective treatment for high risk patients. In 2002 TAVI was performed for the first time in a human by Alain Cribier, using an antegrade access approach via the femoral vein, crossing the intra-atrial septum after puncture and ...
Stortecky Stefan +3 more
openaire +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Transcatheter Aortic Valve Implantation
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2009There has been significant improvement in device designs, operative techniques, and early clinical outcomes in <5 years. Presently, there are two catheter-based bioprostheses (balloon expandable or self-expandable), which have been widely used in humans and are undergoing clinical investigations.
Jian, Ye, Samuel V, Lichtenstein
+7 more sources
Transcatheter Aortic Valve Implantation
Cardiology Clinics, 2010In the 7 years since the first implant, more than 7000 transcatheter aortic valve implantations (TAVI) have been performed worldwide. This article describes the latest available information on this field and the upcoming technological expectations.
Raquel, Del Valle-Fernández +2 more
openaire +2 more sources
Transcatheter Aortic Valve Implantation
Current Atherosclerosis Reports, 2016Severe aortic stenosis (AS) is a life-threatening condition when left untreated. Aortic valve replacement (AVR) is the gold standard treatment for the majority of patients; however, transcatheter aortic valve implantation/replacement (TAVI/TAVR) has emerged as the preferred treatment for high-risk or inoperable patients.
S Chris, Malaisrie +3 more
openaire +2 more sources